10 results on '"Langmuir P"'
Search Results
2. 412 POSTER A first-in-man phase I study of TH-302, a hypoxia-activated cytotoxic prodrug.
3. 6609 POSTER Vandetanib in advanced non-small-cell lung cancer: an ongoing clinical evaluation programme.
4. 3505 ORAL Glufosfamide (GLU) in metastatic pancreatic adenocarcinoma previously treated with gemcitabine: Results of a Phase III trial.
5. 390 TH-302, a tumor selective hypoxia activated prodrug, complements and enhances chemotherapy treatment with gemcitabine, docetaxel, pemetrexed, and doxorubicin.
6. 9004 Vandetanib plus pemetrexed vs pemetrexed as 2nd-line therapy in patients with advanced non-small-cell lung cancer (NSCLC): a randomized, double-blind phase III trial.
7. 1226 Multi-arm Phase IB study of TH-302 in combination with gemcitabine, docetaxel or pemetrexed.
8. 3523 POSTER Glufosfamide (GLU) plus gemcitabine (GEM) in pancreatic adenocarcinoma: results of a Phase 2 trial.
9. 546 A phase I dose-escalation trial of ZD6126 administered as 5 daily dose every 3 weeks to patients with cancer refractory to other treatments.
10. P-113 FIGHT-302: Phase 3 study of first-line pemigatinib vs gemcitabine + cisplatin for cholangiocarcinoma with FGFR2 fusions or rearrangement.
Catalog
Books, media, physical & digital resources
Discovery Service for Jio Institute Digital Library
For full access to our library's resources, please sign in.